Aptinyx Inc (APTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/07/20
Aptinyx Inc. (APTX) CEO Norbert Riedel on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/31/20
Earnings Preview: Aptinyx Inc. (APTX) Q4 Earnings Expected to DeclineZacks Investment Research • 03/23/20
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s DiseaseGlobeNewsWire • 01/30/20
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ OptionGlobeNewsWire • 01/14/20
Aptinyx Initiates Phase 2 Study of NYX-458 in Patients with Mild Cognitive Impairment Associated with Parkinson’s DiseaseGlobeNewsWire • 12/05/19
Aptinyx Inc. (APTX) CEO Norbert Riedel on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
Aptinyx Initiates Two Phase 2 Studies of NYX-2925 in Patients with Chronic Centralized Pain ConditionsGlobeNewsWire • 11/12/19
Earnings Preview: Aptinyx Inc. (APTX) Q3 Earnings Expected to DeclineZacks Investment Research • 11/05/19
Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual MeetingGlobeNewsWire • 10/28/19
Aptinyx to Present Preclinical Data on Three Clinical-Stage NMDA Receptor Modulators at the 49th Annual Meeting of the Society for NeuroscienceGlobeNewsWire • 10/15/19
Aptinyx to Present at the 2019 Cantor Fitzgerald Global Healthcare ConferenceGlobeNewsWire • 09/30/19
Three Recent Preclinical Publications Highlight NMDA Receptor Activation Facilitated by Aptinyx’s NYX-2925GlobeNewsWire • 09/26/19
Former Principal Deputy Commissioner of FDA, Dr. Rachel Sherman, Joins Aptinyx Board of DirectorsGlobeNewsWire • 09/04/19
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head InjuryGlobeNewsWire • 08/21/19
Aptinyx Inc.'s (APTX) CEO Norbert Riedel on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/12/19
Aptinyx Inc. (APTX) CEO Norbert Riedel on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/14/19